FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 3211555 · Received July 8, 2013

Report

Report Number
2124215-2013-09824
Event Type
Malfunction
Date Received
July 8, 2013
Date of Event
May 6, 2013
Report Date
May 6, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KY
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT ATRIAL (RA) LEAD HAS TWIDDLER'S SYNDROME. THIS LEAD WAS NOTED TO HAVE IMPEDANCE MEASUREMENTS GREATER THAN 2,000 OHMS. DURING A ROUTINE DEVICE CHANGE OUT PROCEDURE THIS LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
308695 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4479

Patients

Seq Age Sex Outcome Treatment
1 91 YR 4479| K063| 1290| 4135| 4456